SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MultiCell Technologies, Inc.
MCET 0.000001000-90.0%Jun 6 1:41 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RWS who wrote (99)10/26/2005 9:58:12 AM
From: Tradenride  Read Replies (2) of 237
 
RWS, how much are you down on this pos. Using Immunotherapeutic technology on flu strains is nothing new in the immunotherapeutic area and eliminating a strain entirely has been the demise of such treatment. Sense the therapy only reduces the strain, it reproduced itself. Once investors realize this and the fact that the company is virtually broke, does not even have a lab in San Diego where these test were conducted, eminent insider selling and highly dilutive financing is on the way,, you will just be a bag holder.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News